Published in BMC Genet on February 27, 2008
Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics (2011) 1.63
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin Drug Metab Toxicol (2009) 1.24
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. Curr Drug Metab (2008) 1.09
Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One (2011) 1.07
Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects. Hum Genomics (2009) 1.06
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients. Antimicrob Agents Chemother (2014) 1.01
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics (2014) 0.97
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania. Antimicrob Agents Chemother (2012) 0.95
Empirical distributions of F(ST) from large-scale human polymorphism data. PLoS One (2012) 0.94
Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations. BMC Genet (2010) 0.90
Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations. Pharmacogenomics (2011) 0.84
Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection. BMC Evol Biol (2013) 0.84
Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population. BMC Genet (2014) 0.82
Exploring the relationship between lifestyles, diets and genetic adaptations in humans. BMC Genet (2015) 0.81
Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol. J Antimicrob Chemother (2015) 0.81
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi. Antimicrob Agents Chemother (2015) 0.79
NAT2 gene diversity and its evolutionary trajectory in the Americas. Pharmacogenomics J (2015) 0.78
Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients. Pharmacogenomics J (2016) 0.78
Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics. BMC Genet (2014) 0.77
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania. PLoS One (2015) 0.76
Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data. BMC Med Genet (2009) 0.75
Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations. Ann Lab Med (2017) 0.75
Cornerstones of Toxicology. Toxicol Pathol (2017) 0.75
NAT2 genetic variations among South Indian populations. Hum Genome Var (2014) 0.75
Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa. BMC Evol Biol (2015) 0.75
The International HapMap Project. Nature (2003) 73.65
Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics (1989) 73.50
On the number of segregating sites in genetical models without recombination. Theor Popul Biol (1975) 60.96
Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online (2007) 54.21
Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics (1992) 43.80
Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol (1999) 35.53
The hitch-hiking effect of a favourable gene. Genet Res (1974) 34.74
DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics (2003) 32.63
Adaptive protein evolution at the Adh locus in Drosophila. Nature (1991) 31.65
A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet (2003) 26.59
Statistical tests of neutrality of mutations. Genetics (1993) 24.94
Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00
Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics (1997) 20.93
Estimation of the coancestry coefficient: basis for a short-term genetic distance. Genetics (1983) 15.79
Hitchhiking under positive Darwinian selection. Genetics (2000) 14.72
Linkage disequilibrium in finite populations. Theor Appl Genet (1968) 12.55
Interrogating a high-density SNP map for signatures of natural selection. Genome Res (2002) 10.33
Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad Sci U S A (2005) 10.22
Population structure and human evolution. Proc R Soc Lond B Biol Sci (1966) 8.78
Drift, admixture, and selection in human evolution: a study with DNA polymorphisms. Proc Natl Acad Sci U S A (1991) 8.14
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
Genetic evidence for complex speciation of humans and chimpanzees. Nature (2006) 6.66
Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels. Am J Hum Genet (2001) 5.84
Genomewide comparison of DNA sequences between humans and chimpanzees. Am J Hum Genet (2002) 5.80
The future of association studies: gene-based analysis and replication. Am J Hum Genet (2004) 5.44
Interrogating multiple aspects of variation in a full resequencing data set to infer human population size changes. Proc Natl Acad Sci U S A (2005) 5.21
Evidence for gradients of human genetic diversity within and among continents. Genome Res (2004) 4.70
Measures of human population structure show heterogeneity among genomic regions. Genome Res (2005) 3.68
Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu Rev Genomics Hum Genet (2003) 3.40
Disentangling the effects of demography and selection in human history. Mol Biol Evol (2004) 2.97
Inferences about human demography based on multilocus analyses of noncoding sequences. Genetics (2002) 2.95
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res (2002) 2.62
The value of isolated populations. Nat Genet (2001) 2.51
Pharmacogenetics in the laboratory and the clinic. N Engl J Med (2003) 2.12
Human demographic history: refining the recent African origin model. Curr Opin Genet Dev (2002) 2.00
Pharmacogenetics goes genomic. Nat Rev Genet (2003) 2.00
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet (1995) 1.79
A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc Natl Acad Sci U S A (2002) 1.78
Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am J Hum Genet (2002) 1.61
Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am J Hum Genet (2002) 1.58
Comment on "Genetic structure of human populations". Science (2003) 1.57
The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern. Genome Res (2005) 1.40
Natural selection on the erythrocyte surface. Mol Biol Evol (2002) 1.37
Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J (2002) 1.24
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet (2006) 1.23
Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomarkers Prev (1999) 1.18
Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol (2003) 1.05
Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene. Hum Mutat (2006) 1.04
Pitfalls in N-acetyltransferase 2 genotyping. Pharmacogenetics (1999) 1.03
Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J (2006) 1.00
Arylamine N-acetyltransferases - of mice, men and microorganisms. Trends Pharmacol Sci (2001) 0.99
Complete sequencing of a genetic polymorphism in NAT2 in the Korean population. Clin Chem (2002) 0.93
Arylamine N-acetyltransferases and drug response. Pharmacogenomics (2002) 0.91
The heterozygote advantage in phenylketonuria. Am J Hum Genet (1986) 0.88
Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine. Pharmacogenetics (2002) 0.86
Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population. Clin Pharmacol Ther (1996) 0.80
Relationship between human genotype and phenotype of N-acetyltransferase (NAT2) as estimated by discriminant analysis and multiple linear regression: 1. Genotype and N-acetylation in vivo. Pharmacogenetics (1997) 0.78
No evidence of Neandertal mtDNA contribution to early modern humans. PLoS Biol (2004) 3.81
Revisiting Neandertal diversity with a 100,000 year old mtDNA sequence. Curr Biol (2006) 2.04
A predominantly neolithic origin for Y-chromosomal DNA variation in North Africa. Am J Hum Genet (2004) 2.02
Molecular analysis of the beta-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the beta(S) Senegal mutation. Am J Hum Genet (2001) 1.73
Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica (2005) 1.58
Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Transplantation (2005) 1.52
Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species. PLoS Pathog (2009) 1.35
Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Am J Trop Med Hyg (2003) 1.31
Decreasing the effects of horizontal gene transfer on bacterial phylogeny: the Escherichia coli case study. Mol Phylogenet Evol (2004) 1.27
Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin (2010) 1.23
Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood (2004) 1.22
MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Blood (2009) 1.17
On the use of haplotype phylogeny to detect disease susceptibility loci. BMC Genet (2005) 1.10
Association between Parkinson's disease and the HLA-DRB1 locus. Mov Disord (2012) 1.09
Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One (2011) 1.07
Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol (2005) 1.05
Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in southern Iran. Hum Biol (2006) 1.01
Clustering of haplotypes based on phylogeny: how good a strategy for association testing? Eur J Hum Genet (2006) 1.00
LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB J (2012) 1.00
Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. J Gen Virol (2006) 1.00
Selection-driven transcriptome polymorphism in Escherichia coli/Shigella species. Genome Res (2005) 1.00
Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies. J Psychiatr Res (2009) 0.96
Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J Rheumatol (2003) 0.94
Inferring haplotypes at the NAT2 locus: the computational approach. BMC Genet (2005) 0.93
Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in Moroccan patients. J Infect Dev Ctries (2014) 0.92
MtDNA haplogroup analysis of black Brazilian and sub-Saharan populations: implications for the Atlantic slave trade. Hum Biol (2006) 0.91
Genetic evidence for complexity in ethnic differentiation and history in East Africa. Ann Hum Genet (2009) 0.90
CYP2D6 genetic polymorphism in South Indian populations. Biol Pharm Bull (2006) 0.89
Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol (2008) 0.89
Human genetic differentiation across the Strait of Gibraltar. BMC Evol Biol (2010) 0.89
Genetic variation among major human geographic groups supports a peculiar evolutionary trend in PAX9. PLoS One (2011) 0.89
UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia. Am J Hematol (2006) 0.88
Human neutral genetic variation and forensic STR data. PLoS One (2012) 0.87
Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord (2012) 0.87
Genetic structure of Mediterranean populations revealed by Y-chromosome haplotype analysis. Am J Phys Anthropol (2003) 0.87
Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases. Am J Physiol Cell Physiol (2011) 0.85
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clin Infect Dis (2013) 0.85
Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection. BMC Evol Biol (2013) 0.84
Polymorphism of Toll-like receptor 4 gene in bipolar disorder. J Affect Disord (2013) 0.84
Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis. Intensive Care Med (2011) 0.83
Foetal haemoglobin in normal healthy adults: relationship with polymorphic sequences cis to the beta globin gene. Eur J Hum Genet (2002) 0.83
Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease. Pharmacogenet Genomics (2010) 0.83
Origin of Hb A2' (Hb B2) [delta16(A13)Gly --> Arg (GGC --> CGC)]. Hemoglobin (2003) 0.83
Taiwan Y-chromosomal DNA variation and its relationship with Island Southeast Asia. BMC Genet (2014) 0.83
Warfarin pharmacogenetics: polymorphisms of the CYP2C9, CYP4F2, and VKORC1 loci in a genetically admixed Omani population. Hum Biol (2012) 0.83
MICA variant promotes allosensitization after kidney transplantation. J Am Soc Nephrol (2013) 0.83
Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation. Transplantation (2006) 0.83
The association of CD81 polymorphisms with alloimmunization in sickle cell disease. Clin Dev Immunol (2013) 0.83
Shape variability and classification of human hair: a worldwide approach. Hum Biol (2007) 0.83
The MCP-1 (CCL2) -2518 GG genotype is associated with protection against pulmonary tuberculosis in Moroccan patients. J Infect Dev Ctries (2012) 0.82
Neonatal Screening: Mean haemoglobin and red cell indices in cord blood from Omani neonates. Sultan Qaboos Univ Med J (2011) 0.82
A stepwise α-thalassemia screening strategy in high-prevalence areas. Eur J Haematol (2013) 0.82
Analysis of the French National Registry of unrelated bone marrow donors, using surnames as a tool for improving geographical localisation of HLA haplotypes. Eur J Hum Genet (2003) 0.82
The β-globin promoter -71 C>T mutation is a β+ thalassemic allele. Eur J Haematol (2011) 0.82
Variants of the mannose-binding lectin gene in the Benin population: heterozygosity for the p.G57E allele may confer a selective advantage. 2007. Hum Biol (2009) 0.82
Sodium phenyl butyrate downregulates endothelin-1 expression in cultured human endothelial cells: relevance to sickle-cell disease. Am J Hematol (2007) 0.81
aes, the gene encoding the esterase B in Escherichia coli, is a powerful phylogenetic marker of the species. BMC Microbiol (2009) 0.81
Local population structure in Arabian Peninsula revealed by Y-STR diversity. Hum Hered (2009) 0.81
HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Hum Immunol (2007) 0.81
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa. Eur J Nucl Med Mol Imaging (2013) 0.80
The phylogeography of mitochondrial DNA haplogroup L3g in Africa and the Atlantic slave trade. Am J Hum Genet (2004) 0.80
Profiling posttransplant circulating antibodies in kidney transplantation using donor endothelial cells. Transplantation (2012) 0.80
Genetic structure of Algerian populations. Am J Hum Biol (2006) 0.80
Circulating endothelial cell protein C receptor: endothelial regulation and cumulative impact of gender and A3 haplotype. J Vasc Res (2011) 0.80
Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium. Hematol J (2004) 0.79
SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype. Genet Med (2006) 0.79
Variants of the mannose-binding lectin gene in the Benin population: heterozygosity for the p.G57E allele may confer a selective advantage. Hum Biol (2007) 0.79
Novel spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis in ethnic Omani patients. Am J Hematol (2007) 0.79
An inframe perforin gene deletion in familial hemophagocytic lymphohistiocytosis is associated with perforin expression. Am J Hematol (2005) 0.79
Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.79
Data-mining methods as useful tools for predicting individual drug response: application to CYP2D6 data. Hum Hered (2006) 0.78
Polymorphisms in oxidative stress-related genes are associated with nasopharyngeal carcinoma susceptibility. Immunobiology (2015) 0.78
Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease. Hum Immunol (2013) 0.78
Haematological and clinical features of beta-thalassaemia associated with Hb Dhofar. Eur J Haematol (2008) 0.78
Interictal type 1 cannabinoid receptor binding is increased in female migraine patients. Headache (2011) 0.78
Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. J Hum Genet (2012) 0.78
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis (2011) 0.78
Beta-globin-like gene cluster haplotypes in hemoglobinopathies. Methods Mol Med (2003) 0.77
On the use of phylogeny-based tests to detect association between quantitative traits and haplotypes. Genet Epidemiol (2009) 0.77
Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors. FEMS Microbiol Lett (2002) 0.77
Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation. Front Immunol (2011) 0.77
Molecular basis of thalassemia in Qatar. Hemoglobin (2007) 0.77
Angiotensinogen gene associated polymorphisms and risk of stroke in sickle cell anemia: Additional data supporting an association. Am J Hematol (2004) 0.76
Distribution of Y chromosome lineages in Jerba island population. Forensic Sci Int (2005) 0.76
A novel deletional beta-thalassemic variant in an ethnic Qatari patient. Hemoglobin (2009) 0.76
Endothelial cells do not express GSTA1: potential relevance to busulfan-mediated endothelial damage during haematopoietic stem cell transplantation. Eur J Haematol (2008) 0.76
Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells. J Innate Immun (2016) 0.76
Contribution to the description of the beta-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin (2004) 0.76
Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data. BMC Med Genet (2009) 0.75
Hb A2' (Hb B2) in the Omani population and diagnostic significance. Hemoglobin (2011) 0.75
Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study. Eur J Haematol (2011) 0.75
Molecular spectrum of β-thalassemia mutations in the admixed Venezuelan population, and their linkage to β-globin gene haplotypes. Hemoglobin (2012) 0.75
Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica. Clin Rheumatol (2010) 0.75
Hb Sheffield [β58(E2)Pro→His] in Oman: potential pitfall in genetic counseling. Hemoglobin (2011) 0.75
A novel beta-thalassemia mutation in an Asian Indian. Hemoglobin (2002) 0.75
A new high A2-beta-thalassemia due to a 468 bp deletion (-475 to -8) in the beta-globin gene promoter of the intact beta-globin structural gene. Hemoglobin (2004) 0.75
Isotopic biomarker discovery and application in translational medicine. Drug Discov Today (2009) 0.75
Hb Lepore in the Indian population. Hemoglobin (2003) 0.75